The rise in obesity, type 2 diabetes, and other metabolic disorders has led to a need for more effective treatments. Semaglutide, an analog of human glucagon-like peptide-1 (GLP-1) is a novel therapy that has shown great promise in clinical trials and is now available as a prescription drug. In this article, we will explore the mechanisms and potential benefits of semaglutide and consider how it may be used in weight management, diabetes treatment, and other medical applications.